Manitoba Pharmacy Jurisprudence Practice Exam

The initial step in the drug review process is always the submission of a New Drug Submission (NDS) to Health Canada. This NDS contains detailed information on the drug's ingredients, manufacturing process, clinical trial results, and proposed labeling. Option A is incorrect because public voting is not a part of the drug review process. Option C is incorrect because large scale human trials usually occur later in the drug review process. Option D is incorrect because drugs are reviewed by a team of healthcare professionals, not just pharmacists.